Volker Moebus

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

Volker Moebus, Christian Jackisch, Hans-Joachim Lueck et al. · Journal of Clinical Oncology · 2010 · 192 citations · Full text

Five genes from chromosomal band 8p22 are significantly down‐regulated in ovarian carcinoma

Dietmar Pils, Peter Horak, Cornelia Sax et al. · Cancer · 2005 · 100 citations · Full text

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer – a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group

Andreas du Bois, HJ Lück, Jacobus Pfisterer et al. · Annals of Oncology · 2001 · 68 citations

Dose-finding Study, Medicine, Metronomic Therapy +8

Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer

Andreas du Bois, Werner Meier, Hans‐Joachim Lück et al. · Annals of Oncology · 2002 · 54 citations

Hormonal Treatment, Medicine, Randomised Trial +8